Found 61 matching trials
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer PHASE2 PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Show More Learn More & Join Trial
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function NA Complaints about memory and thinking are common in women as they go through...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
RWE About QOL and Compliance of Patients With OFS in China N/A The purpose of this study is to assess the patient's feedback from using Gn...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer PHASE3 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Learn More & Join Trial
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy N/A Hormone receptor-positive breast cancer accounts for about 70% of all breas...
Show More Location
Cancer Hospital Affiliated to Harbin Medical University
Learn More & Join Trial
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer PHASE2 To explore the efficacy and safety of chidamide combined with endocrine in ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients PHASE2 Primary Objectives:
* To determine the effectiveness of the 3-month depot ...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Sexual Health and Rehabilitation After Ovarian Suppression Treatment NA This research study is evaluating an educational intervention for breast ca...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk PHASE4 Among ER+HER2- premenopausal patients with N1 who undergoes primary breast ...
Show More Location
Gangnam Severance Hospital
Learn More & Join Trial
Premenopausal Endocrine Responsive Chemotherapy Trial PHASE3 The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Show More Location
National Institute of Oncology
Learn More & Join Trial